In lieu of an abstract, here is a brief excerpt of the content:

169 Index Abraham, John, 23 African Americans and diabetes, 37, 47–49, 125 Aiello, Leslie, 36 Alexander, Jeffrey, 32 American Diabetes Association (ADA), 5, 6 antidiabetics, 36. See also phar­ma­ceu­ti­cals attention deficit/hyperactivity disorder (ADHD), 22 Bell, Susan E., 24 biomedicalization: definition of, 31–32; globalization and, 30–32, 74; language of, 35; scope of, 24–30, 130–32 Black Health Library Guide to Diabetes (Henry and Johnson), 48–49 blood sugar management, 6, 88, 92–93, 106 body mass index (BMI), 2, 12, 26 carbohydrates, 6, 40, 61–62, 68–69, 89, 117 CDC (Centers for Disease Control and Prevention), 6, 47 Charmaz, Kathy, 113, 133–34, 135 Chinese medicine, 16, 17, 21, 72, 102 cholesterol, 119–20 Clarke, Adele E., 73–74; et al., 24–25 compliance to adherence shift, 86 culture, 32, 35; medical practices and, 7–9, 35; durability of, 7 Davidson, Mayer B., and Debra L. Gordon, 38–39, 40 depression (and antidepressants), 22–23, 81–82 diabetes education, 4, 5, 13, 26, 47, 64, 68, 71, 92; shortage of educators, 96 diabetes mellitus (DM), 27, 97 disease definition, 8, 21 domestic management of diabetes, 105, 110–28; ­women and, 14, 29, 110, 116–17, 123 Douglas, Mary, 112 eating disorders, 22–23 evidence-­based medicine (EBM), 6, 7, 8, 9, 16, 18–19, 21, 130 evolution, 40, 53, 57, 58, 64–66, 73 “exercise prescription,” 85, 101–2 explanatory models, 7, 14, 33–38 passim, 41, 47, 72, 88, 110, 113, 117–22, 127, 142n5 fasting blood glucose (FBG), 5, 129 Figert, Anne E., 24 folk cures. See traditional medicine food and eating habits: in Japan, 1–2, 4, 6, 13, 28, 29, 52–53, 56, 58–71, 106, 114–15, 124; in the West, 29, 38–43, 46–49, 63–64, 66 Freeman, Joshua, 41 furusato (hometown village), 65, 71–72 gargling, 15 German medicine, 17 GlaxoSmithKline, 21 globalization, 30, 31, 129–30 Gluckman, Peter, and Mark Hanson, 39–40 Gordon, Debra L., 38–39–40 grounded theory, 133–34 170 Index Hansen’s disease, 21 Hanson, Mark, 39–40 Hata, Tsutomu, 60 Health Japan 21 program, 3 Healthy ­People 2000 program, 3 hemoglobin A1c (HbA1c), 2, 5–6, 12, 29, 90, 121 hikikomori, 22–23 Hosekijima, 12, 115, 116, 119, 123, 135, 136, 137, 140 Hurley, Dan, 142n2 illness narratives, 7, 8, 14, 111, 122, 123, 127 impaired glucose tolerance (IGT), 5–6, 26–27, 52, 69, 109 International Diabetes Federation, 130 Jansen, Marius B., 16 Japan: biomedicalization in, 25, 51–52; colonial outrages by, 17, 141n1 (chap. 1); health care system in, 3, 5, 9–11, 20–21, 107, 141n2; health risk surveillance in, 27–29; health visits frequency in, 4–5, 26, 105, 107; history of medicine in, 15–17; identity and uniqueness (nihonjinron) in, 27, 33, 35, 52, 53–60, 65–67, 72–73, 110, 143n1; local vs. global in, 30; mass media health programming in, 25–26, 28–29, 142n4; ­mental distress in, 22–23; national insurance system in, 11, 20, 141n1; nostalgia in, 71–72; overseas ­children of, 143n2; patient notebook tracking in, 6, 104–5; phar­ma­ceu­ti­cal industry in, 23–24; physicians in, 6–7, 10, 15–16, 18, 19, 20, 64–65, 86, 95–96, 99, 105, 110, 124–27; public health interventions in, 3–4; “radio exercise” in, 25; return (saishin) patients in, 96, 105; ste­reo­ types of, 30–31; suicide in, 22 Japan and type 2 diabetes: explanatory models of, 117–22; gendered attitudes­toward, 122–24; optimistic expectations in, 95, 103–6, 108–9; origin stories of, 13, 28, 34, 52–53, 56–74; physiological susceptibility to, 2, 56, 59, 66; pre-­illness focus in, 26–27, 52; provider–­patient relationship and, 7, 92–109; rates for, 2; treatment for, 4–6, 52; ­women and, 117–24. See also domestic management of diabetes; food; “ordered” life Japan Diabetes Society, 6, 68, 69 Japa­nese ­women. See ­under domestic management of diabetes; Japan and type 2 diabetes Japan Multigenerational Interview Proj­ect, 12 kampo. See ­under traditional medicine Kleinman, Arthur, 33–34, 38, 142n5 Lamont, Michelle, 14 lifestyle diseases, 2, 3, 13, 39–40 lifestyle modification, 5, 6, 26, 85, 88–89, 104, 106–7. See also “exercise prescription” local vs. global pro­cesses, 30–33, 34 locus of control, 90–91 Lock, Margaret, 21 Loewe, Ron, 41 Lutfey, Karen, et al., 87 medicalization, 20–25 metabolic syndrome, 3, 21 metformin, 129. See also phar...

pdf

Additional Information

ISBN
9781469646701
Related ISBN
9781469646671
MARC Record
OCLC
1062421772
Pages
186
Launched on MUSE
2018-12-03
Language
English
Open Access
No
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.